Prime Medicine, Inc. (NASDAQ: PRME)
$2.9200
-0.2300 ( -6.11% ) 522.0K
Prime Medicine Inc is a biotechnology company committed to delivering genetic therapies to address diseases by deploying gene editing technology, Prime Editing. The Prime Editing technology is a next-generation technology that can search and replace to restore normal genetic function in the genome and can treat a wide spectrum of diseases with high unmet medical needs and efficient and broad gene editing technology.
Market Data
Open
$2.9200
Previous close
$3.1500
Volume
522.0K
Market cap
$392.83M
Day range
$2.9000 - $3.1750
52 week range
$2.5600 - $9.7700
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | May 21, 2024 |
4 | Insider transactions | 1 | May 21, 2024 |
4 | Insider transactions | 1 | May 21, 2024 |
8-k | 8K-related | 15 | May 10, 2024 |
10-q | Quarterly Reports | 62 | May 10, 2024 |
def | Proxies and info statements | 4 | Apr 29, 2024 |
ars | Annual reports | 1 | Apr 29, 2024 |
pre | Proxies and info statements | 4 | Apr 19, 2024 |
4 | Insider transactions | 1 | Mar 04, 2024 |
8-k | 8K-related | 16 | Mar 01, 2024 |